Therapeutic potential of 5-[125I]iodo-2′-deoxyuridine and methotrexate in the treatment of advanced neoplastic meningitis

International Journal of Radiation Biology

Volumn 80, Issue 11-12, 2004, Pages 941-946

  Kassis, Amin I ^a   Kirichian, Agop M ^a   Wang, Ketai ^a   Semnani, Elham Safaie ^a   Adelstein, S James ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IDOXURIDINE I 125; METHOTREXATE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CALCULATION; CELL KILLING; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; MENINGITIS; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DRUG SYNERGISM; IDOXURIDINE; INJECTIONS, SPINAL; MENINGEAL NEOPLASMS; MENINGITIS; METHOTREXATE; PALLIATIVE CARE; PARALYSIS; RADIATION TOLERANCE; RADIOPHARMACEUTICALS; RATS; RHABDOMYOSARCOMA; SEVERITY OF ILLNESS INDEX; SPINAL NEOPLASMS; TREATMENT OUTCOME;

ANIMALIA;

EID: 12344306166     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/09553000400017671     Document Type: Conference Paper

References (33)

1. 125IUdR) by resistant cancer. The British Journal of Radiology, 64, 37-44.
2. BERRY, M. P., JENKIN, R. D. T., KEEN, C. W., NAIR, B. D. and SIMPSON, W. J., 1981, Radiation treatment for medulloblastoma: a 21-year review. Journal of Neurosurgery, 55, 43-51.
3. BLEYER, W. A., DRAKE, J. C. and CHABNER, B. A., 1973, Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. The New England Journal of Medicine, 289, 770-773.
4. BRADLEY, E. W., CHAN, P. C. and ADELSTEIN, S. J., 1975, The radiotoxicity of iodine-125 in mammalian cells I. Effects on the survival curve of radioiodine incorporated into DNA. Radiation Research, 64, 555-563.
5. 123I. Radiation Research, 87, 10-23.
6. DEANGELIS, L. M., 1998, Current diagnosis and treatment of leptomeningeal metastasis. Journal of Neuro-oncology, 38, 245-252.
7. EIDINOFF, M. L., CHEONG, L., GAMBETTA GURPIDE, E., BENUA, R. S. and ELLISON, R. R., 1959, Incorporation of 5-iodouracil labelled with iodine-131 into the deoxyribonucleic acid of human leukaemic leucocytes following in vivo administration of 5-iododeoxyuridine labelled with iodine-131. Nature, 183, 1686-1687.
8. FOULON, C. F., ADELSTEIN, S. J. and KASSIS, A. I., 1996, Kit formulation for the preparation of radiolabeled iododeoxyuridine by demetallation. The Journal of Nuclear Medicine, 37(4, suppl.), 1S-3S.
9. GARRETT, C., WATAYA, Y. and SANTI, D. V., 1979, Thymidylate synthetase. Catalysis of dehalogenation of 5-bromo- and 5-iodo-2′-deoxyuridylate. Biochemistry, 18, 2798-2804.
10. GROSSMAN, S. A. and MOYNIHAN, T. J., 1991, Neoplastic meningitis. Neurologic Clinics, 9, 843-856.
11. GROSSMAN, S. A., FINKELSTEIN, D. M., RUCKDESCHEL, J. C., TRUMP, D. L., MOYNIHAN, T. and ETTINGER, D. S. for the Eastern Cooperative Oncology Group, 1993, Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Journal of Clinical Oncology, 11, 561-569.
12. 131iodine. Radiation Research, 47, 94-109.
13. KASSIS, A. I., SASTRY, K. S. R. and ADELSTEIN, S. J., 1985, Intracellular localisation of Auger electron emitters: biophysical dosimetry. Radiation Protection Dosimetry, 13, 233-236.
14. 125I in mammalian cells. Radiation Research, 111, 305-318.
15. 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes. Radiation Research, 109, 78-89.
16. KASSIS, A. I., HOWELL, R. W., SASTRY, K. S. R. and ADELSTEIN, S. J., 1988, Positional effects of Auger decays in mammalian cells in culture. In DNA Damage by Auger Emitters, edited by K. F. Baverstock and D. E. Charlton (London: Taylor and Francis), pp 1-13.
17. 123I: the use of the Auger effect as a biological probe at the nanometre level. Radiation Protection Dosimetry, 31, 333-338.
18. KASSIS, A. I., ADELSTEIN, S. J. and MARIANI, G., 1996, Radiolabeled nucleoside analogs in cancer diagnosis and therapy. The Quarterly Journal of Nuclear Medicine, 40, 301-319.
19. 125I]iodo-2′- deoxyuridine. Acta Oncologica, 39, 731-737.
20. MACKINTOSH, F. R., COLBY, T. V., PODOLSKY, W. J., BURKE, J. S., HOPPE, R. T., ROSENFELT, F. P., ROSENBERG, S. A. and KAPLAN, H. S., 1982, Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer, 49, 586-595.
21. 123I]iodo-2′-deoxyuridine in patients with liver metastases from colorectal cancer. Acta Oncologica, 35, 941-945.
22. 125I]iodo-deoxyuridine incorporation into tumour and normal tissue DNA by methotrexate and thymidylate synthase inhibitors. European Journal of Cancer, 32A, 1603-1608.
23. PATCHELL, R. A. and POSNER, J. B., 1985, Neurologic complications of systemic cancer. Neurologic Clinics, 3, 729-750.
24. 125IUdR in cultured mouse BP8 tumour cells. British Journal of Cancer, 25, 594-597.
25. SHAPIRO, W. R., POSNER, J. B., USHIO, Y., CHERNIK, N. L. and YOUNG, D. F., 1977, Treatment of meningeal neoplasms. Cancer Treatment Reports, 61, 733-743.
26. STEWART, D. J., KEATING, M. J., MCCREDIE, K. B., SMITH, T. L., YOUNESS, E., MURPHY, S. G., BODEY, G. P. and FREIREICH, E. J., 1981, Natural history of central nervous system acute leukemia in adults. Cancer, 47, 184-196.
27. TRUMP, D. L., GROSSMAN, S. A., THOMPSON, G., MURRAY, K. and WHARAM, M., 1982, Treatment of neoplastic meningitis with intraventricular thiotepa and methotrexate. Cancer Treatment Reports, 66, 1549-1551.
28. WALICKA, M. A., ADELSTEIN, S. J. and KASSIS, A. I., 1998, Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: double-strand breaks. Radiation Research, 149, 134-141.
29. WARTERS, R. L. and HOFER, K. G., 1977, Radionuclide toxicity in cultured mammalian cells: elucidation of the primary site for radiation-induced division delay. Radiation Research, 69, 348-358.
30. WASSERSTROM, W. R., GLASS, J. P. and POSNER, J. B., 1982, Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer, 49, 759-772.
31. WINKELMAN, M. D. and HINES, J. D., 1983, Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study. Annals of Neurology, 14, 520-527.
32. XUE, L. Y., BUTLER, N. T., MAKRIGIORGOS, G. M., ADELSTEIN, S. J. and KASSIS, A. I., 2002a, Bystander effect produced by radiolabeled tumor cells in vivo. Proceedings of the National Academy of Sciences of the United States of America, 99, 13765-13770.
33. 125I-iodo- 2′-deoxyuridine in the treatment of neoplastic meningitis. The Journal of Nuclear Medicine, 43(5, suppl.), 278P.